510(k) Report

FDA applicant

Respironics New Jersey, Inc.

Cedar Grove, NJ5 decisions2004–20111 recall

FDA records 5 decisions for Respironics New Jersey, Inc. (Cedar Grove, NJ) from 2004 to 2011: 5 510(k) clearances. Most are in product codes CAF (Nebulizer (Direct Patient Interface)) and NVP (Holding Chambers, Direct Patient Interface). Its devices cite 9 predicates, 0 of them its own earlier devices. 1 recall is linked to its devices.

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) refreshed weekly, last Nov 3, 2026

FIG. A — Illustration, anesthesiology panel, where it files most

How often FDA has decided Respironics New Jersey, Inc.’s devices, and how often a recall has named them.

FDA decisions per year

1in 2011

2007: 12010: 12011: 1
2007high 1 (2007) · low 0 (2008)2026

2026 so far, outlined.

Recalls per year

1in 2021

2021: 1
2007high 1 (2021) · low 0 (2007)2026

Class I Class II/III not classified

FIG. 1 — Respironics New Jersey, Inc. by year, 2007–2026Sources: FDA decision databases, recall and enforcement reports · Data through Oct 25, 2026

Planning a device like Respironics New Jersey, Inc.’s? A 510(k) Report ranks candidate predicates for your device by lineage, citations and recall history, with the review-time outlook.

See the 510(k) Report

Other applicant names beginning “Respironics”

FDA records each applicant name separately; these may or may not be the same firm.